Third Harmonic Bio, Inc. (THRD)
Jul 31, 2025 - THRD was delisted
5.38
-0.00 (-0.09%)
Inactive · Last trade price on Jul 30, 2025
Accolade Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Accolade stock have an average target of 5.00, which predicts a -7.06% decrease from the current stock price of 5.38.
Price Target: $5.00 (-7.06%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 28, 2025.
Analyst Ratings
The average analyst rating for Accolade stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy → Hold Downgrades $23 → $5 | Strong Buy → Hold | Downgrades | $23 → $5 | -7.06% | Mar 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $20 → $5 | Buy → Hold | Downgrades | $20 → $5 | -7.06% | Feb 12, 2025 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 11, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $12 → $20 | Hold → Buy | Upgrades | $12 → $20 | +271.75% | Aug 9, 2024 |
| Stifel | Stifel | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +327.51% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.94
from -1.09
EPS Next Year
-0.97
from -0.94
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.97 | -1.00 | -1.00 |
| Avg | -0.94 | -0.97 | -0.97 |
| Low | -0.90 | -0.93 | -0.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.